Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Jean Bousquet, Josep M Antó, Bernardo Sousa‐Pinto, Wienczyslawa Czarlewski, Anna Bedbrook, Tari Haahtela, Ludger Klimek, Oliver Pfaar, Piotr Kuna, Maciej Kupczyk, Frederico S. Regateiro, Bolesław Samoliński, Arūnas Valiulis, Arzu Yorgancıoğlu, S. Arnavielhe, Xavier Basagaña, Karl‐Christian Bergmann, Sinthia Bosnic‐Anticevich, Luisa Brussino, Giorgio Walter Canonica, Victória Cardona, Lorenzo Cecchi, Claudia Chaves‐Loureiro, Elı́sio Costa, Ãlvaro A. Cruz, Bilun Gemicioğlu, Wytske J. Fokkens, Juan Carlos Ivancevich, Helga Kraxner, Violeta Kvedarienė, Désirée Larenas‐Linnemann, Daniel Laune, Renaud Louis, Μichael Μakris, Marcus Maurer, Erik Melén, Yann Micheli, Mário Morais‐Almeida, Joaquim Mullol, Marek Niedoszytko, Yoshitaka Okamoto, Nikolaos G. Papadopoulos, Vincenzo Patella, N. Pham‐Thi, Philip W. Rouadi, J. Sastre, Nicola Scichilone, Aziz Sheikh, Mikhail Sofiev, Luís Taborda‐Barata, Sanna Toppila‐Salmi, Ioanna Tsiligianni, Erkka Valovirta, Maria Teresa Ventura, Rafael José Vieira, Mihaela Zidarn, Rita Amaral, Ignacio J. Ansotegui, Annabelle Bédard, Samuel Benveniste, M. Bewick, Carsten Bindslev‐Jensen, Hubert Blain, Matteo Bonini, Rodolphe Bourret, Fulvio Braido, Pedro Martins, D. Charpin, Iván Chérrez-Ojeda, Tomás Chivato, Derek K. Chu, Cemal Cingi, Stefano Del Giacco, F. de Blay, Philippe Devillier, Govert de Vries, Maria Doulaptsi, Virginie Doyen, Gérard Dray, J.F. Fontaine, René Maximiliano Gómez, Jan Hagemann, Enrico Heffler, Maja A. Hofmann, Ewa Jassem, Marek Jutel, Thomas Keil, Vicky Kritikos, Inger Kull, Marek Kulus, Olga Lourenço, Eve Mathieu‐Dupas, Enrica Menditto, Ralph Mösges, Ruth Murray, Rachel Nadif, Hugo Neffen, Stefania Nicola, Robyn E. O’Hehir, Heidi Olze
Abstract
Abstract MASK‐air ® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK‐air ® is a Good Practice of DG Santé on digitally‐enabled, patient‐centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co‐operation and Development). MASK‐air ® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK‐air ® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as‐needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom‐medication score (ARIA‐EAACI‐CSMS) has been validated for clinical practice and trials. The implications of the novel MASK‐air ® results should lead to change management in rhinitis and asthma.